A commonly prescribed drug easing nerve pain is now associated with dementia and cognitive impairment.

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

The Central Drugs Standard Control Organisation (CDSCO) has released a list of 17 drugs, if expired, to be flushed down the ...

The ancient Greek physician and botanist Dioscorides is considered by many to be the father of pharmacology for authoring De ...

In a move that could prove detrimental to public health, homeopaths will soon be able to prescribe modern medicines in ...

An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...